Pfizer Q3 EPS $1.34 Beats $1.09 Estimate, Sales $24.10B Beat $22.71B Estimate; Raises Guidance

Pfizer (NYSE:PFE) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.09 by 22.94 percent. This is a 86.11 percent increase over earnings of $0.72 per share from the same period last year. The company reported quarterly sales of $24.10 billion which beat the analyst consensus estimate of $22.71 billion by 6.12 percent. This is a 98.66 percent increase over sales of $12.13 billion the same period last year.